On Jan 21, 2022 Desentum closed a Venture – Series Unknown round and raised €8,000,000 from Springvest, featuring lead investors Springvest.

About the company: Desentum is located at Finland, Europe.
“Desentum is a biopharmaceutical company developing novel types of allergen immunotherapy products (allergy vaccines) that actually change the way the immune system reacts to allergens.”

Company website: http://www.desentum.fien